StockData
MetaVia Inc. logo

MetaVia Inc. (MTVA) stock

MTVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.06−0.19 (-15.20%)

Close on Nov 18, 2026Market cap $6.98MP/E –Yield –

MetaVia free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

MetaVia's free cash flow for the twelve months ending Dec 31, 2025 was -$15.70M. For fiscal 2025 it was -$15.70M. The highest annual figure on record is -$7.25M in fiscal 2019.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.70M–
FY2024Dec 31, 2024-$24.72M–
FY2023Dec 31, 2023-$10.85M–
FY2021Dec 31, 2021-$15.14M–
FY2020Dec 31, 2020-$10.77M–
FY2019Dec 31, 2019-$7.25M–
FY2018Dec 31, 2018-$14.45M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025-$4.86M–
Q3 FY2025Sep 30, 2025-$2.96M–
Q4 FY2024Dec 31, 2024-$5.47M–
Q3 FY2024Sep 30, 2024-$5.55M–
Q2 FY2024Jun 30, 2024-$7.25M–
Q1 FY2024Mar 31, 2024-$6.45M–
Q4 FY2023Dec 31, 2023-$3.40M–
Q3 FY2023Sep 30, 2023-$2.85M–
Q2 FY2023Jun 30, 2023-$2.05M–
Q1 FY2023Mar 31, 2023-$2.55M–
Q4 FY2021Dec 31, 2021-$2.90M–
Q3 FY2021Sep 30, 2021-$2.51M–
Q4 FY2020Dec 31, 2020-$2.35M–
Q3 FY2020Sep 30, 2020-$1.95M–
Q2 FY2020Jun 30, 2020-$2.32M–
Q1 FY2020Mar 31, 2020-$4.14M–
Q4 FY2019Dec 31, 2019-$1.37M–
Q3 FY2019Sep 30, 2019-$3.44M–

More MetaVia figures

See a number that looks wrong?